ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION (G/GEJ) ADENOCARCINOMA

Clinical trials for ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION (G/GEJ) ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION (G/GEJ) ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION (G/GEJ) ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for stomach cancer: triple therapy shows promise in early trial

Disease control Ongoing

This study tests a combination of three treatments (anlotinib, TQB2450, and chemotherapy) as a first-line therapy for people with advanced stomach or gastroesophageal junction cancer that has low PD-L1 expression. The goal is to see if this combination can shrink tumors and contr…

Matched conditions: ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION (G/GEJ) ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Yongxu Jia • Aim: Disease control

Last updated May 18, 2026 12:11 UTC

ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION (G/GEJ) ADENOCARCINOMA

Get alerted when new ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION (G/GEJ) ADENOCARCINOMA trials appear

New hope for stomach cancer: triple therapy shows promise in early trial